Abbott Laboratories Operating Income Over Time
| ABT Stock | USD 112.68 1.21 1.09% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Abbott Laboratories Performance and Abbott Laboratories Correlation. Is there potential for Health Care Equipment & Supplies market expansion? Will Abbott introduce new products? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.81) | Dividend Share 2.4 | Earnings Share 3.72 | Revenue Per Share | Quarterly Revenue Growth 0.044 |
Abbott Laboratories's market price often diverges from its book value, the accounting figure shown on Abbott's balance sheet. Smart investors calculate Abbott Laboratories' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Abbott Laboratories' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Abbott Laboratories' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Abbott Laboratories represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Abbott Laboratories and related stocks such as Novo Nordisk AS, Merck Company, and Thermo Fisher Scientific Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | 733.3 M | 22.4 B | 29.5 B | 31.5 B | 34.5 B | 49.4 B | 48.4 B | 49 B | 47.2 B | 52.5 B | 54.1 B | 58.6 B | 74.8 B | 102.6 B | 128.3 B | 129.8 B | 136.3 B |
| MRK | 839.8 M | 9 B | 9.9 B | 7.7 B | 6.7 B | 7.5 B | 5.5 B | 6.8 B | 8.9 B | 7.9 B | 5.5 B | 13.2 B | 18.3 B | 3 B | 20.2 B | 26.8 B | 28.1 B |
| TMO | 4.9 M | 1.5 B | 1.6 B | 1.8 B | 2.3 B | 2.5 B | 2.9 B | 3.3 B | 3.9 B | 4.3 B | 7.9 B | 10.3 B | 8.5 B | 6.9 B | 7.7 B | 8.1 B | 8.5 B |
| NVS | 5 B | 10.8 B | 11.5 B | 11 B | 11.1 B | 9 B | 8.3 B | 8.7 B | 8.4 B | 9.1 B | 10.2 B | 10.1 B | 7.9 B | 9.8 B | 14.5 B | 17.1 B | 9.6 B |
| BSX | 70.5 M | 1.1 B | 994 M | 871 M | 845 M | 790 M | 1.2 B | 1.5 B | 1.7 B | 1.7 B | 601 M | 1.9 B | 1.8 B | 2.2 B | 2.6 B | 4 B | 4.2 B |
| MDT | 76.3 M | 4.5 B | 4.4 B | 3.8 B | 3.8 B | 5.4 B | 5.4 B | 6.6 B | 6.3 B | 4.8 B | 4.5 B | 5.8 B | 5.5 B | 5.1 B | 6 B | 6.8 B | 7.2 B |
| SYK | 14.6 M | 2 B | 1.9 B | 2.1 B | 2.2 B | 2.3 B | 2.6 B | 2.8 B | 3.1 B | 3.4 B | 3 B | 3.8 B | 3.7 B | 4.3 B | 5.1 B | 5.6 B | 5.9 B |
| ISRG | (30.8 M) | 694.8 M | 878.1 M | 852.5 M | 544.8 M | 740 M | 945.2 M | 1.1 B | 1.2 B | 1.4 B | 1 B | 1.8 B | 1.6 B | 1.8 B | 2.3 B | 2.9 B | 3.1 B |
| UNH | 4.1 M | 8.5 B | 9.3 B | 9.6 B | 10.3 B | 11 B | 12.9 B | 15.2 B | 17.3 B | 19.7 B | 22.4 B | 24 B | 28.4 B | 32.4 B | 32.3 B | 19 B | 19.9 B |
| GILD | (4.8 M) | 3.8 B | 4 B | 4.5 B | 15.3 B | 22.2 B | 17.6 B | 14.1 B | 8.2 B | 4.3 B | 4.1 B | 9.9 B | 7.3 B | 7.6 B | 1.7 B | 11.8 B | 12.4 B |
Abbott Laboratories and related stocks such as Novo Nordisk AS, Merck Company, and Thermo Fisher Scientific Operating Income description
Operating Income is the amount of profit realized from Abbott Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Abbott Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Abbott Laboratories | ABT |
| Classification | Compulsion |
| Business Address | 100 Abbott Park |
| Exchange | New York Stock Exchange |
USD 112.68
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.